Zusammenfassung
In diesem Kapitel über die akute Höhenkrankheit (AMS) soll versucht werden, praxisrelevante und allgemeinverständliche Handlungsempfehlungen zu vermitteln, die eine deutliche Risikoreduktion und einen beschwerdefreien Aufstieg in große und extreme Höhen erlauben. Gerade in unserer modernen Leistungsgesellschaft, in der offensichtlich der schnelle Erfolg allzu häufig unser Handeln bestimmt, und umgekehrt Freizeit zum kostbaren Gut erklärt wird, geraten wir beim Höhenbergsteigen in einen nahezu unlösbaren Interessenskonflikt. Darüber soll in den folgenden Abschnitten auch durchaus kontrovers berichtet werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Ayus JC, Moritz ML (2008) Exercise-associated hyponatremia masqerading as acute mountain sickness: are we missing the diagnosis? Clin J Sport Med 18: 383–386
Bailey DM, Bärtsch P, Knauth M, Baumartner RW (2009a) Emerging concepts in acute mountain sickness and high altittude cerebral edema: form the molecular to the morphological. Cell Mol Life Sci 66: 3583–3594
Bailey DM, Taudorf S, Berg RM et al. (2009b) Increased cerebral output of free radicals during hypoxia: implications for acute mountain sickness? Am J Physiol Regul Integr Comp Physiol 297: R 1238–1292
Basnyat B, Lemaster J, Litch JA (1999) Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243m in the Himalayas. Aviat Space Environ Med 70: 867–873
Basnyat B, Gertsch JH, Holck PS et al. (2006) Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the pevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy trial. High Alt Med Biol 7: 17–27
Bloch KE, Turk AJ, Maggiorini M et al. (2009) Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m. High Al Med Biol 10: 25–32
Davies AJ, Kalson NS, Stokes S et al. (2009) Determinants of summiting success and acute mountain sickness on Mt Kilimajaro 5895 m. Wilderness Environ Med 20: 311–317
De Acosta I (1590) Historia Natural y Moral de las Indias, Lib 3, Cap. 9, luan de Leon, Seville
Dumont L, Mardirosoff C, Tramer MR (2000) Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ 321, S 267–272
Ellsworth AJ, Meyer EF, Larson EB (1991) Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier. West. J Med 154: 289–293
Ferrazzini G, Maggiorini M, Friemler S et al. (1987) Successful treatment of acute mountain sickness with dexamethasone. BMJ 294: 1380–1382
Fitch RF (1964) Mountain sickness: a cerebral form. Ann. Intern. Med. 60: 871–876
Hackett PH, Roach RC, Wood RA et al. (1988) Dexamethasone for prevention and treatment of acute montain sickness. Aviat Space Environ Med 59: 950–954
Hackett PH, Roach RC (2001) Current concepts: high-altitude Illness. N Engl J Med 345: 107–114
Hackett PH, Rennie D (1979) Rales, peripheral edema, retinal hemorrhage and acute mountain sickness. Am J Med 67: 214–218
Houston, CS. (1960) Acute pulmonary edema of high altitude. N Engl J Med 263: 478–80
Houston, CS, Dickinson J (1975) Cerebral form of high-altitude illness. Lancet 2: 758–761
Hultgren H, Spickard W (1960) Medical experiences in Peru. Stanford Med Bull 18: 97–98
Kallenberg K, Bailey FM, Christ S et al. (2007) Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J Cereb Blood Flow Metab 27: 1064–1071
Kalson NS, Thompson J, Davie AJ et al. (2009) The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro 5895m. Eur J Appl Physiol 105: 373–379
Karinen H, Peltonen J, Tikkanen H (2008) Prevalence of acute mountain sickness among Finnish trekkers on Mount Kilimanjaro, Tanzania: an ovservational study. High Alt Med Biol 9: 301–306
Kayser B, Dumont L, Lysakowski C et al. (2012) Reappraisal of acetazolamide for the prevention of acute mountain sickness: A systematic review and meta-analysis. High Alt Med Biol 13: 82–92
Kim JW, Tchernyshyov I, Semenza GL et al. (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3: 177–185
Levine BD, Yoshimura K, Kobayashi T et al. (1989) Dexamethasone in the treatment of acute mountain sickness. N Engl J Med 321: 1707–1713
Luks AM, Swenson ER (2008) Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness. Chest 133: 744–755
Luks AM, McIntosh SE, Grissom CK et al. (2010) Wilderness Medical Society consensus guidelines fort he prevention and treatment of acute altitude Illness. Wilderness Environ. Med 21: 146–155
Maggiorini M, Muller A, Hofstetter D et al. (1998) Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat. Space Environ Med 69: 1186–1192
Murdoch DR (1999) How fast is too fast? Attempts to define a recommended ascent rate to prevent acute mountain sickness. ISMM Newsletter 9: 3–6
Pesce C, Leal C, Pinto H et al. (2005) Determinants of acute mountain sickness and success on Mount Aconcagua 6962 m. High Al Med Biol 6: 158–166
Ravenhill TH (1913) Some experience of mountain sickness in the Andes. J Trop Med Hyg 16: 313–320
Richalet JP, Larmignat P, Poitrine E et al. (2011) Physiological risk factors of severe high altitude illness: a prospective cohort study. Am J Respir Crit Care Med 185: 192–198
Richardson A, Wat P, Maxwell N (2009) Hydration and the physiological responses to acute normobaric hypoxia. Wilderness Environ. Med 20: 212–220
Roach RC, Bärtsch P, Hackett PH, Oelz O (1993) The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Houston CS, Coates G (Hrsg) Hypoxia and mountain medicine. Queen City Printers, Burlington, VT, S 272–274
Roach RC, Maes D, Sandoval D et al. (2000) Exercise exacerbates acute mountain sickness at simulated high altitude. J Appl Physiol 88: 581–585
Schneider M, Bernasch D, Weymann J et al. (2002) Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med Sci. Sports Exerc 34: 1886–1891
Schoonmann GG, Sandor PS, Nirkko AC et al. (2008) Hypoxia-induced acute mountain sickness is associated with intracelllular cerebral edema: a 3 T magnetic resonance imaging study. J Cereb Blood Flow Metab 28: 198–206
Silber E, Sonnenberg P, Collier DJ et al. (2003) Clinical features of headache at altitude: a prospective study. Neurology 60: 1167–1171
Swenson ER, Teppema LJ (2007) Prevention of acute mountain sickness by acetazolamide: as yet an unfinished sotroy. J Appl Physiol 102: 1305–1307
Van Osta A, Moraine JJ, Melot C et al. (2005) Effects of high altitude exposure on cerebral hemodynamics in normal subjects. In: Stroke 36, S 557–560
Wang P, Koehle MS, Rupert JL (2010) No association between alleles of the bradykinin receptor-B2 gene and acute mountain sickness. Exp Biol Med 235: 737–740
West JB, Lahiri S, Gill MB et al. (1962) Arterial oxygen saturation during exercise at high altitude. J Appl Physiol.17: 617–621
West JB (1996) T.H. Ravenhill and his contributions to mountain sickness. J Appl Physiol 80: 715–724
West JB (1998) High Life: A history of high-altitude physiology and medicine. Oxford University Press, New York
West JB (2004) The physiologic basis of high-altitude disease. Ann Intern Med 141: 789–800
West JB (2011) Con: Headache should not be a required symptom fort he diagnosis of acute mountain sickness. High Alt Med Biol 12: 23–25; discussion 27
Wilson DF, Roy A, Lahiri S (2005) Immediate and long-term responses of the carotid body to high altitude. High Alt Med Biol 6: 97–111
Wu TY, Ding SQ, Liu JL et al. (2009) Reduced incidence and severity of acute mountain sickness in Qinghai-Tibet railroad construction workers ater repeated 7-month exposures despite 5-month low altitude periods. High Alt Med Biol 10: 221–232
Wu TY, Ding SQ, Zhang SL et al. (2010) Altitude illness in Qinghai-Tibet railroad passengers. High Alt Med Biol 11: 189–198
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Wien
About this chapter
Cite this chapter
Schaffert, W. (2015). Akute Höhenkrankheit (AMS). In: Berghold, F., et al. Alpin- und Höhenmedizin. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1833-7_42
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1833-7_42
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1832-0
Online ISBN: 978-3-7091-1833-7
eBook Packages: Medicine (German Language)